350 related articles for article (PubMed ID: 36432531)
1. Sodium Alginate Prevents Non-Alcoholic Fatty Liver Disease by Modulating the Gut-Liver Axis in High-Fat Diet-Fed Rats.
Zhao H; Gao X; Liu Z; Zhang L; Fang X; Sun J; Zhang Z; Sun Y
Nutrients; 2022 Nov; 14(22):. PubMed ID: 36432531
[TBL] [Abstract][Full Text] [Related]
2. Astragalus mongholicus polysaccharides ameliorate hepatic lipid accumulation and inflammation as well as modulate gut microbiota in NAFLD rats.
Zhong M; Yan Y; Yuan H; A R; Xu G; Cai F; Yang Y; Wang Y; Zhang W
Food Funct; 2022 Jul; 13(13):7287-7301. PubMed ID: 35726797
[TBL] [Abstract][Full Text] [Related]
3. Berberine inhibits liver damage in rats with non-alcoholic fatty liver disease by regulating TLR4/MyD88/NF-κB pathway.
Wang L; Jia Z; Wang B; Zhang B
Turk J Gastroenterol; 2020 Dec; 31(12):902-909. PubMed ID: 33626003
[TBL] [Abstract][Full Text] [Related]
4. Coffee prevents fatty liver disease induced by a high-fat diet by modulating pathways of the gut-liver axis.
Vitaglione P; Mazzone G; Lembo V; D'Argenio G; Rossi A; Guido M; Savoia M; Salomone F; Mennella I; De Filippis F; Ercolini D; Caporaso N; Morisco F
J Nutr Sci; 2019; 8():e15. PubMed ID: 31037218
[TBL] [Abstract][Full Text] [Related]
5. Regulatory effect of a Chinese herbal medicine formula on non-alcoholic fatty liver disease.
Yang JM; Sun Y; Wang M; Zhang XL; Zhang SJ; Gao YS; Chen L; Wu MY; Zhou L; Zhou YM; Wang Y; Zheng FJ; Li YH
World J Gastroenterol; 2019 Sep; 25(34):5105-5119. PubMed ID: 31558860
[TBL] [Abstract][Full Text] [Related]
6. Structural modulation of gut microbiota during alleviation of non-alcoholic fatty liver disease with Gynostemma pentaphyllum in rats.
Shen SH; Zhong TY; Peng C; Fang J; Lv B
BMC Complement Med Ther; 2020 Feb; 20(1):34. PubMed ID: 32024509
[TBL] [Abstract][Full Text] [Related]
7. Inulin Exerts Beneficial Effects on Non-Alcoholic Fatty Liver Disease via Modulating gut Microbiome and Suppressing the Lipopolysaccharide-Toll-Like Receptor 4-Mψ-Nuclear Factor-κB-Nod-Like Receptor Protein 3 Pathway via gut-Liver Axis in Mice.
Bao T; He F; Zhang X; Zhu L; Wang Z; Lu H; Wang T; Li Y; Yang S; Wang H
Front Pharmacol; 2020; 11():558525. PubMed ID: 33390939
[No Abstract] [Full Text] [Related]
8. Lycopene prevents non-alcoholic fatty liver disease through regulating hepatic NF-κB/NLRP3 inflammasome pathway and intestinal microbiota in mice fed with high-fat and high-fructose diet.
Gao X; Zhao X; Liu M; Zhao H; Sun Y
Front Nutr; 2023; 10():1120254. PubMed ID: 37032779
[TBL] [Abstract][Full Text] [Related]
9. [Intervention of Catalpol on High-fat Diet Induced Nonalcoholic Fatty Liver Disease in Mice].
Tian X; Xiong Q; Chen L; Wen JR; Ru Q
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Dec; 41(6):746-755. PubMed ID: 31907123
[No Abstract] [Full Text] [Related]
10. [Effect of diosgenin on mTOR/FASN/HIF-1α/VEGFA expression in rats with non-alcoholic fatty liver disease].
Yin GL; Liang HY; Liang PP; Feng YN; Chen SW; Liu XY; Pan WC; Zhang FX
Zhongguo Zhong Yao Za Zhi; 2023 Apr; 48(7):1760-1769. PubMed ID: 37282950
[TBL] [Abstract][Full Text] [Related]
11. Free fatty acids, not triglycerides, are associated with non-alcoholic liver injury progression in high fat diet induced obese rats.
Liu J; Han L; Zhu L; Yu Y
Lipids Health Dis; 2016 Feb; 15():27. PubMed ID: 26868515
[TBL] [Abstract][Full Text] [Related]
12. Hydrogen inhalation ameliorates hepatic inflammation and modulates gut microbiota in rats with high-fat diet-induced non-alcoholic fatty liver disease.
Xue J; Zhao M; Liu Y; Jia X; Zhang X; Gu Q; Xie Y; Qin S; Liu B
Eur J Pharmacol; 2023 May; 947():175698. PubMed ID: 36997047
[TBL] [Abstract][Full Text] [Related]
13. Huangqin decoction mitigates hepatic inflammation in high-fat diet-challenged rats by inhibiting TLR4/NF-κB/NLRP3 pathway.
Yan BF; Wang Y; Wang WB; Ding XJ; Wei B; Liu SJ; Fu TM; Chen L; Zhang JZ; Liu J; Zheng X
J Ethnopharmacol; 2023 Mar; 303():115999. PubMed ID: 36509260
[TBL] [Abstract][Full Text] [Related]
14. [Gynostemma pentaphyllum saponins alleviate non-alcoholic fatty liver disease in rats by regulating intestinal flora and short-chain fatty acid metabolism].
Zhong FW; Li GX; Zeng L
Zhongguo Zhong Yao Za Zhi; 2022 May; 47(9):2500-2508. PubMed ID: 35531697
[TBL] [Abstract][Full Text] [Related]
15. Oral Administration of Compound Probiotics Ameliorates HFD-Induced Gut Microbe Dysbiosis and Chronic Metabolic Inflammation via the G Protein-Coupled Receptor 43 in Non-alcoholic Fatty Liver Disease Rats.
Liang Y; Liang S; Zhang Y; Deng Y; He Y; Chen Y; Liu C; Lin C; Yang Q
Probiotics Antimicrob Proteins; 2019 Mar; 11(1):175-185. PubMed ID: 29353414
[TBL] [Abstract][Full Text] [Related]
16. [Study of the effect of liraglutide on the correlation between NLRP3 inflammasome and non-alcoholic fatty liver disease].
Ma ZZ; Ao N; Yang N; Yang J; Jin S; Du C; Du J
Zhonghua Gan Zang Bing Za Zhi; 2022 Jun; 30(6):624-630. PubMed ID: 36038324
[No Abstract] [Full Text] [Related]
17. Long-term subcutaneous injection of lipopolysaccharides and high-fat diet induced non-alcoholic fatty liver disease through IKKε/ NF-κB signaling.
He Q; Zeng J; Yao K; Wang W; Wu Q; Tang R; Xia X; Zou X
Biochem Biophys Res Commun; 2020 Nov; 532(3):362-369. PubMed ID: 32883523
[TBL] [Abstract][Full Text] [Related]
18. Esculeogenin A, a Glycan from Tomato, Alleviates Nonalcoholic Fatty Liver Disease in Rats through Hypolipidemic, Antioxidant, and Anti-Inflammatory Effects.
Al Jadani JM; Albadr NA; Alshammari GM; Almasri SA; Alfayez FF; Yahya MA
Nutrients; 2023 Nov; 15(22):. PubMed ID: 38004149
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation.
Andrade JM; Paraíso AF; de Oliveira MV; Martins AM; Neto JF; Guimarães AL; de Paula AM; Qureshi M; Santos SH
Nutrition; 2014; 30(7-8):915-9. PubMed ID: 24985011
[TBL] [Abstract][Full Text] [Related]
20. Mussel polysaccharide α-D-glucan (MP-A) protects against non-alcoholic fatty liver disease via maintaining the homeostasis of gut microbiota and regulating related gut-liver axis signaling pathways.
Wu J; Shao H; Zhang J; Ying Y; Cheng Y; Zhao D; Dou X; Lv H; Li S; Liu F; Ling P
Int J Biol Macromol; 2019 Jun; 130():68-78. PubMed ID: 30797009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
